Pathogenesis of chronic obstructive pulmonary disease
- PMID: 17720039
- DOI: 10.1016/j.ccm.2007.06.008
Pathogenesis of chronic obstructive pulmonary disease
Abstract
The pathogenesis of chronic obstructive pulmonary disease (COPD) encompasses a number of injurious processes, including an abnormal inflammatory response in the lungs to inhaled particles and gases. Other processes, such as failure to resolve inflammation, abnormal cell repair, apoptosis, abnormal cellular maintenance programs, extracellular matrix destruction (protease/antiprotease imbalance), and oxidative stress (oxidant/antioxidant imbalance) also have a role. The inflammatory responses to the inhalation of active and passive tobacco smoke and urban and rural air pollution are modified by genetic and epigenetic factors. The subsequent chronic inflammatory responses lead to mucus hypersecretion, airway remodeling, and alveolar destruction. This article provides an update on the cellular and molecular mechanisms of these processes in the pathogenesis of COPD.
Similar articles
-
Pathogenesis of COPD.Semin Respir Crit Care Med. 2005 Apr;26(2):142-53. doi: 10.1055/s-2005-869535. Semin Respir Crit Care Med. 2005. PMID: 16088433 Review.
-
Functional significance of apoptosis in chronic obstructive pulmonary disease.COPD. 2007 Dec;4(4):347-53. doi: 10.1080/15412550701603775. COPD. 2007. PMID: 18027162 Review.
-
[Effects of smoking on the pathogenesis of COPD].Nihon Rinsho. 2007 Apr;65(4):605-10. Nihon Rinsho. 2007. PMID: 17419375 Japanese.
-
Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms.Cell Biochem Biophys. 2005;43(1):167-88. doi: 10.1385/CBB:43:1:167. Cell Biochem Biophys. 2005. PMID: 16043892 Review.
-
Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.COPD. 2010 Aug;7(4):291-306. doi: 10.3109/15412555.2010.496818. COPD. 2010. PMID: 20673039 Review.
Cited by
-
Reduction of neutrophilic lung inflammation by inhalation of the compatible solute ectoine: a randomized trial with elderly individuals.Int J Chron Obstruct Pulmon Dis. 2016 Oct 18;11:2573-2583. doi: 10.2147/COPD.S115061. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27799756 Free PMC article. Clinical Trial.
-
Mucolytic and Antioxidant Properties of Carbocysteine as a Strategy in COVID-19 Therapy.Life (Basel). 2022 Nov 8;12(11):1824. doi: 10.3390/life12111824. Life (Basel). 2022. PMID: 36362979 Free PMC article. Review.
-
Evaluation of von Willebrand factor in COPD patients.J Bras Pneumol. 2014 Jul-Aug;40(4):373-9. doi: 10.1590/s1806-37132014000400004. J Bras Pneumol. 2014. PMID: 25210959 Free PMC article.
-
Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD.Int J Chron Obstruct Pulmon Dis. 2016 Oct 31;11:2729-2736. doi: 10.2147/COPD.S112882. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27843309 Free PMC article.
-
(-)-Epigallocatechin-3-gallate Reduces Cigarette Smoke-Induced Airway Neutrophilic Inflammation and Mucin Hypersecretion in Rats.Front Pharmacol. 2017 Sep 6;8:618. doi: 10.3389/fphar.2017.00618. eCollection 2017. Front Pharmacol. 2017. PMID: 28932196 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical